News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mediland Pharm.
RELATED STOCKHEAD STORIES
News
July Winners Column: Rare earths, engineering and takeover target stocks reigned supreme on the ASX
News
Hot Money Monday: Rumble Resources is the hottest stock on the ASX in the last fortnight
News
Here’s what Australia’s daigou trade will look like in 2021, once international students return
News
These ASX China exporting stocks have been able to shrug off trade tensions (so far)
News
How TikTok is helping the daigou trade not only survive, but thrive
News
The retail small caps that weathered the COVID storm better than their peers
News
Immigration at record lows in March but tourism could boom post-COVID-19
News
Going viral: Don’t go catching falling knives
News
Retail: The Chinese dollar made these companies, now it may sink them
News
Spies and corporate takeovers: what’s next for the China-Australia story?
News
Is retail really struggling? Small cap retail stocks up 6 per cent in six months
Food & Agriculture
Asia’s appetite for Aussie infant formula players is on the rise
Health & Biotech
The ASX’s first Chinese tourism retail play Mediland Pharm makes its debut
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Mediland Pharm rides the wave of rising Chinese tourism
IPO Watch